Cardax, Inc. (CDXI) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2800 WOODLAWN DRIVE HONOLULU, HI 96822 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2021 MRQ | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 19 | 19 | 244 | 2,237 | 158 | 323 | |||
| Cash and cash equivalents | 19 | 19 | 244 | 2,237 | 158 | 323 | |||
| Receivables | 206 | 157 | 37 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 994 | 1,178 | 1,480 | 340 | 11 | ||||
| Inventory | 994 | 1,178 | 1,480 | 340 | 11 | ||||
| Prepaid expense | 105 | 181 | 24 | 23 | 20 | 3 | |||
| Deposits current assets | 3 | 2 | 119 | 91 | 123 | 88 | |||
| Total current assets: | 1,122 | 1,586 | 2,024 | 2,728 | 312 | 414 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1 | 12 | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 2 | 8 | 14 | ||||||
| Intangible assets, net (including goodwill) | 302 | 420 | 435 | 427 | 431 | 424 | |||
| Intangible assets, net (excluding goodwill) | 302 | 420 | 435 | 427 | 431 | 424 | |||
| Total noncurrent assets: | 303 | 433 | 435 | 429 | 439 | 438 | |||
| TOTAL ASSETS: | 1,425 | 2,019 | 2,459 | 3,157 | 751 | 852 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,689 | 1,544 | 1,996 | 603 | 657 | 663 | |||
| Employee-related liabilities | 50 | 50 | 50 | 50 | 50 | 50 | |||
| Other undisclosed accounts payable and accrued liabilities | 1,639 | 1,494 | 1,946 | 553 | 607 | 613 | |||
| Debt | 769 | 587 | |||||||
| Derivative instruments and hedges, liabilities | 235 | ||||||||
| Due to related parties | 769 | 419 | 419 | 419 | 419 | 419 | |||
| Other undisclosed current liabilities | 7,089 | 5,584 | 3,487 | 3,540 | 3,560 | 3,519 | |||
| Total current liabilities: | 10,552 | 8,133 | 5,902 | 4,562 | 4,636 | 4,600 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 1 | ||||||||
| Liabilities, other than long-term debt | 1,072 | 1,084 | 93 | ||||||
| Accounts payable and accrued liabilities | 72 | 84 | 93 | ||||||
| Due to related parties | 1,000 | 1,000 | |||||||
| Operating lease, liability | 1 | ✕ | ✕ | ✕ | ✕ | ||||
| Total noncurrent liabilities: | 1,072 | 1,085 | 93 | ||||||
| Total liabilities: | 11,623 | 9,218 | 5,994 | 4,562 | 4,636 | 4,600 | |||
| Equity | |||||||||
| Equity, attributable to parent | (10,198) | (7,199) | (3,535) | (1,405) | (3,886) | (3,748) | |||
| Common stock | 1 | 1 | 134 | 123 | 85 | 69 | |||
| Additional paid in capital | 61,893 | 59,837 | 58,274 | 56,401 | 51,963 | 50,333 | |||
| Deferred compensation equity | (10) | ||||||||
| Accumulated deficit | (72,092) | (67,036) | (61,943) | (57,919) | (55,934) | (54,150) | |||
| Total equity: | (10,198) | (7,199) | (3,535) | (1,405) | (3,886) | (3,748) | |||
| TOTAL LIABILITIES AND EQUITY: | 1,425 | 2,019 | 2,459 | 3,157 | 751 | 852 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 539 | 711 | 1,511 | 610 | 35 | 48 | ||
| Other income | 1 | 17 | 48 | |||||
| Cost of revenue (Cost of Goods and Services Sold) | (196) | (345) | (700) | (275) | (15) | (10) | ||
| Gross profit: | 343 | 366 | 811 | 336 | 21 | 38 | ||
| Operating expenses | (3,405) | (4,443) | (4,834) | (2,338) | (1,851) | (4,401) | ||
| Other undisclosed operating loss | (38) | |||||||
| Operating loss: | (3,063) | (4,077) | (4,022) | (2,002) | (1,830) | (4,401) | ||
| Nonoperating income (expense) | (1,993) | (1,016) | (2) | 17 | 47 | 143 | ||
| Investment income, nonoperating | 2 | 3 | 2 | 2 | ||||
| Debt instrument, convertible, beneficial conversion feature | 350 | |||||||
| Other nonoperating income | 30 | 47 | ||||||
| Interest and debt expense | 395 | (623) | (4) | (4) | (3) | (2) | ||
| Loss from continuing operations before equity method investments, income taxes: | (4,661) | (5,716) | (4,028) | (1,989) | (1,787) | (4,260) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (395) | 623 | 4 | 4 | 3 | 2 | ||
| Loss from continuing operations: | (5,056) | (5,093) | (4,024) | (1,985) | (1,784) | (4,258) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (5,056) | (5,093) | (4,024) | (1,985) | (1,784) | (4,258) | |
| Net loss available to common stockholders, basic: | (5,056) | (5,093) | (4,024) | (1,985) | (1,784) | (4,258) | ||
| Other undisclosed net loss available to common stockholders, diluted | (13) | |||||||
| Net loss available to common stockholders, diluted: | (5,056) | (5,107) | (4,024) | (1,985) | (1,784) | (4,258) | ||
Comprehensive Income ($ in thousands)
| 3/31/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (5,056) | (5,093) | (4,024) | (1,985) | (1,784) | (4,258) | ||
| Comprehensive loss, net of tax, attributable to parent: | (5,056) | (5,093) | (4,024) | (1,985) | (1,784) | (4,258) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.